---
layout: butir
authors: [viridi]
title: refs
pid: '0050'
mathjax: false
chartjs: false
ptext: false
x3dom: false
threejs: false
3dmol: false
oo: false
svgphys: false
category: literatures
tags: ["ivermectin", "curse of knowledge", "the things you can see", "when you slow down"]
date: 2021-06-28 21:31:00 +0700
permalink: /0050
src: https://github.com/dudung/butir/commits/main/_posts/0/05/2021-06-28-refs.md
twitter_username: 6unpnp
nodes: ['0000']
---
Today issues are curse of knowledge [[1](#r1)], ivermectin [[2](#r2),[3](#r3),[4](#r4),[5](#r5)], and benefit of seeing something when slowing down [[6](#r6)]. I might read the last, but do not know for sure :laughing:. Try to integrate `lx` and butir. Forget to record the offer from Dhito (AIDI) about creating chatbot using Scratch for students [[7](#r7)] and Kakak is informed. She is interested in it and will also ask friends from TechOne.


## notes
1. <a name=r1></a>Jane Kennedy, "Debiasing the Curse of Knowledge in Audit Judgment", The Accounting Review [Account. Rev.], vol. 70, no. 2, pp. 249-273, Apr 1995, url <https://www.jstor.org/stable/248305> `AccountRev-70-2-249-1995`
2. <a name=r2></a>Leon Caly, Julian D. Druce, Mike G. Catton, David A. Jans, Kylie M. Wagstaff, "The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in
vitro", Antiviral Research [Antivir. Res.], vol. 178, no., p. 104787, Jun 2020, url <https://doi.org/10.1016/j.antiviral.2020.104787> `AntivirRes-178-104787-2020`
3. <a name=r3></a>Henrique Pott-Junior, Mônica Maria Bastos Paoliello, Alice de Queiroz Constantino Miguel, Anderson Ferreirada Cunha, Caio Cesarde Melo Freire, Fábio Fernandes Neves, Lucimar Rettoda Silva de Avó, Meliza Goi Roscani, Sigrid De Sousados Santos, Silvana Gama Florêncio Chachá, "Use of ivermectin in the treatment of Covid-19: A pilot trial", Toxicology Reports [Toxicol. Rep.], vol. 8, no., pp. 505–510, 2021, url <https://doi.org/10.1016/j.toxrep.2021.03.003> `ToxicolRep-8-505-2021`
4. <a name=r4></a>Sabeena Ahmed, Mohammad Mahbubul Karim, Allen G. Ross, Ahmedul Kabir, Asma Binte Aziz, Wasif Ali Khan, "A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness", International Journal of Infectious Diseases [Int. J. Infect. Dis.], vol. 103, no., pp. 214–216, Feb 2021, url <https://doi.org/10.1016/j.ijid.2020.11.191>  `IntJInfectDis-103-214-2021`
5. <a name=r5></a>Alejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, Marina Travacio, Ricardo Valentini, Daniel F. Alonso, Rubén Solari, Marcelo A. Tinelli, Rubén O. Cimino, Luis Álvarez, Pedro E. Fleitas, Laura Ceballos, Marcelo Golemba, Florencia Fernández, Diego Fernández de Oliveira, German Astudillo, Inés Baeck, Javier Farina, Georgina A. Cardama, Andrea Mangano, Eduardo Spitzer, Silvia Gold, Carlos Lanusse, "Antiviral effect of high-dose ivermectin in adults with COVID-19: A proofof-concept randomized trial", EClinicalMedicine [EClinicalMedicine], vol. 37, no., p. 100959, Jul 2021, url <https://doi.org/10.1016/j.eclinm.2021.100959> `EClinicalMedicine-37-100959-2021`
6. <a name=r6></a>Haemin Sunim, "The Things You Can See Only When You Slow Down", Penguin Books, New York, Dec 2017, url <https://isbnsearch.org/isbn/9780143130772> `CanSeeSlowDown-Sunim-2012`
7. <a name=r7></a>-, "Young Technaut: Belajar Membuat Chatbot dengan Scratch", Technaut, 3 Jul 2021, 0900-1130, url <https://technaut.id/event/ytcb/> [20210628].


## &nbsp;
[introduction](0000)
